Baicalin attenuates focal cerebral ischemic reperfusion injury through inhibition of nuclear factor κB p65 activation

Biochemical and Biophysical Research Communications

Volumn 403, Issue 3-4, 2010, Pages 398-404

  Xue, Xia ^a   Qu, Xian Jun ^a   Yang, Ying ^b   Sheng, Xie Huang ^a   Cheng, Fang ^a   Jiang, E Nang ^a   Wang, Jian hua ^a   Bu, Wen ^a   Liu, Zhao Ping ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Baicalin; Focal cerebral ischemia reperfusion injury; Middle cerebral artery occlusion (MCAO); Neuroprotective effect; NF B p65

Indexed keywords

BAICALIN; EOSIN; HEMATOXYLIN; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BRAIN CORTEX; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; GROWTH INHIBITION; HIPPOCAMPUS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INJECTION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; WESTERN BLOTTING;

ANIMALS; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; FLAVONOIDS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; REPERFUSION INJURY; TRANSCRIPTION FACTOR RELA;

ANIMALIA; RATTUS NORVEGICUS; SCUTELLARIA BAICALENSIS;

EID: 78650170987     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.11.042     Document Type: Article

References (35)

1. Elkind M.S. Outcomes after stroke: Risk of recurrent ischemic stroke and other events. Am. J. Med. 2009, 122:S7-13.
2. Schwaninger M., Inta I., Herrmann O. NF-kappaB signalling in cerebral ischaemia. Biochem. Soc. Trans. 2006, 34:1291-1294.
3. Alonso de Lecinana M., Gutierrez M., Roda J.M., et al. Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke. J. Neurol. Sci. 2006, 247:121-129.
4. Szewka A.J., Prabhakaran S. An update on acute ischemic stroke therapies. Compr. Ther. 2009, 35:72-80.
5. Goldstein L.B., Rothwell P.M. Advances in prevention and health services delivery 2007. Stroke 2008, 39:258-260.
6. Sacchetti M.L. Is it time to definitely abandon neuroprotection in acute ischemic stroke?. Stroke 2008, 39:1659-1660.
7. D'Ambrosio A.L., Pinsky D.J., Connolly E.S. The role of the complement cascade in ischemia/reperfusion injury: Implications for neuroprotection. Mol. Med. 2001, 7:367-382.
8. Chen B., Liao W.Q., Xu N., et al. Adiponectin protects against cerebral ischemia-reperfusion injury through anti-inflammatory action. Brain Res. 2009, 1273:129-137.
9. Janardhan V., Qureshi A.I. Mechanisms of ischemic brain injury. Curr. Cardiol. Rep. 2004, 6:117-123.
10. Mehta S.L., Manhas N., Raghubir R. Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res. Rev. 2007, 54:34-66.
11. Cheng Y., Ping J., Xu H.D., et al. Synergistic effect of a novel oxymatrine-baicalin combination against hepatitis B virus replication, alpha smooth muscle actin expression and type I collagen synthesis in vitro. World J. Gastroenterol. 2006, 12:5153-5159.
12. Li B.Q., Fu T., Yan Y.D., et al. Inhibition of HIV infection by baicalin-a flavonoid compound purified from Chinese herbal medicine. Cell. Mol. Biol. Res. 1993, 39:119-124.
13. Jung S.H., Kang K.D., Ji D., Fawcett R.J., et al. The flavonoid baicalin counteracts ischemic and oxidative insults to retinal cells and lipid peroxidation to brain membranes. Neurochem. Int. 2008, 53:325-337.
14. Tian H., Zhang X., Wu C., Chen L., et al. Effects of baicalin and octreotide on the serum TNF-alpha level and apoptosis in multiple organs of rats with severe acute pancreatitis. Inflammation 2009, 32:191-201.
15. Li-Weber M. New therapeutic aspects of flavones: The anticancer properties of Scutellaria and its main active constituents wogonin, baicalein and baicalin. Cancer Treat. Rev. 2009, 35:57-68.
16. Lee H.H., Yang L.L., Wang C.C., et al. Differential effects of natural polyphenols on neuronal survival in primary cultured central neurons against glutamate- and glucose deprivation-induced neuronal death. Brain Res. 2003, 986:103-113.
17. Li H., Wang H., Chen J.H., et al. Determination of amino acid neurotransmitters in cerebral cortex of rats administered with baicalin prior to cerebral ischemia by capillary electrophoresis-laser-induced fluorescence detection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2003, 788:93-101.
18. Tu X.K., Yang W.Z., Shi S.S., et al. Neuroprotective effect of baicalin in a rat model of permanent focal cerebral ischemia. Neurochem. Res. 2009, 34:1626-1634.
19. Longa E.Z., Weinstein P.R., Carlson S., et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20:84-91.
20. Wei X., Liu H., Sun X., et al. Hydroxysafflor yellow A protects rat brains against ischemia-reperfusion injury by antioxidant action. Neurosci. Lett. 2005, 386:58-62.
21. Zhang X.L., An L.J., Bao Y.M., et al. d-Galactose administration induces memory loss and energy metabolism disturbance in mice: Protective effects of catalpol. Food Chem. Toxicol. 2008, 46:2888-2894.
22. Huang H.D., Liu Z.H., Zhu X.J., et al. Inhibition of mycophenolic acid on NF-kappaB activity in human endothelial cells. Acta Pharmacol. Sin. 2002, 23:649-653.
23. Okutucu B., Dincer A., Habib O., et al. Comparison of five methods for determination of total plasma protein concentration. J. Biochem. Biophys. Methods 2007, 70:709-711.
24. Ge Q.F., Hu X., Ma Z.Q., et al. Baicalin attenuates oxygen-glucose deprivation-induced injury via inhibiting NMDA receptor-mediated 5-lipoxygenase activation in rat cortical neurons. Pharmacol. Res. 2007, 55:148-157.
25. Gao Z., Huang K., Xu H. Protective effects of flavonoids in the roots of Scutellaria baicalensis Georgi against hydrogen peroxide-induced oxidative stress in HS-SY5Y cells. Pharmacol. Res. 2001, 43:173-178.
26. Yi J.H., Park S.W., Kapadia R., et al. Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damage. Neurochem. Int. 2007, 50:1014-1027.
27. Wen Y.D., Zhang H.L., Qin Z.H. Inflammatory mechanism in ischemic neuronal injury. Neurosci. Bull. 2006, 22:171-182.
28. Collino M., Aragno M., Mastrocola R., et al. Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion. Eur. J. Pharmacol. 2006, 530:70-80.
29. Kim J.W., Jin Y.C., Kim Y.M., et al. Daidzein administration in vivo reduces myocardial injury in a rat ischemia/reperfusion model by inhibiting NF-kappaB activation. Life Sci. 2009, 84:227-234.
30. Yang L., Tao L.Y., Chen X.P. Roles of NF-kappaB in central nervous system damage and repair. Neurosci. Bull. 2007, 23:307-313.
31. Duckworth E.A., Butler T., Collier L., et al. NF-kappaB protects neurons from ischemic injury after middle cerebral artery occlusion in mice. Brain Res. 2006, 1088:167-175.
32. Clemens J.A., Stephenson D.T., Smalstig E.B., et al. Global ischemia activates nuclear factor-kappa B in forebrain neurons of rats. Stroke 1997, 28:1073-1080. discussion 1080-1081.
33. Malek R., Borowicz K.K., Jargiello M., et al. Role of nuclear factor kappaB in the central nervous system. Pharmacol. Rep. 2007, 59:25-33.
34. Zhang H.L., Gu Z.L., Savitz S.I., et al. Neuroprotective effects of prostaglandin A(1) in rat models of permanent focal cerebral ischemia are associated with nuclear factor-kappaB inhibition and peroxisome proliferator-activated receptor-gamma up-regulation. J. Neurosci. Res. 2008, 86:1132-1141.
35. Nurmi A., Lindsberg P.J., Koistinaho M., et al. Nuclear factor-kappaB contributes to infarction after permanent focal ischemia. Stroke 2004, 35:987-991.